262 related articles for article (PubMed ID: 36620928)
1. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
3. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
4. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil.
Titton CM; Torikachvili M; Rêgo HMC; Medronha EF; Ziemiecki Junior E; Ribas C; Ceratti CG; Mattos AA; Tovo CV
Rev Assoc Med Bras (1992); 2023; 69(4):e20220944. PubMed ID: 37075438
[TBL] [Abstract][Full Text] [Related]
6. Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis.
Li Y; Guo Y; Wang X; Gao L
Abdom Radiol (NY); 2024 Feb; 49(2):575-585. PubMed ID: 37980601
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
8. Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.
Berenguer M
Acta Gastroenterol Belg; 2023; 86(2):318-322. PubMed ID: 37428165
[TBL] [Abstract][Full Text] [Related]
9. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
Cheng S; Hu G; Jin Z; Wang Z; Xue H
Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
Benmassaoud A; Roccarina D; Arico F; Leandro G; Yu B; Cheng F; Yu D; Patch D; Tsochatzis E
Am J Gastroenterol; 2020 Nov; 115(11):1911-1914. PubMed ID: 33156111
[TBL] [Abstract][Full Text] [Related]
13. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
Krieger S; Jauss M; Jansen O; Stiehl A; Sauer P; Geissler M; Theilmann L; Krieger D
J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
[TBL] [Abstract][Full Text] [Related]
14. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
15. Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Wang C; Teng Y; Gao J; Zhang Z; Li Y
Abdom Radiol (NY); 2023 Apr; 48(4):1454-1467. PubMed ID: 36735033
[TBL] [Abstract][Full Text] [Related]
16. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
[TBL] [Abstract][Full Text] [Related]
17. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
19. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
20. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.
Sanyal AJ; Freedman AM; Shiffman ML; Purdum PP; Luketic VA; Cheatham AK
Hepatology; 1994 Jul; 20(1 Pt 1):46-55. PubMed ID: 8020904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
